Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Abilify Maintena (aripiprazole 400 mg + inert substance) modified release injection, syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
aripiprazole 400 mg + inert substance modified release injection, syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 128 mg/0.36 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 96 mg/0.27 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Buvidal Monthly 128 mg/0.36 mL modified release injection, 0.36 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 64 mg/0.18 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Buvidal Monthly 96 mg/0.27 mL modified release injection, 0.27 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 32 mg/0.64 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Buvidal Weekly 32 mg/0.64 mL modified release injection, 0.64 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Buvidal Monthly 64 mg/0.18 mL modified release injection, 0.18 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 24 mg/0.48 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Buvidal Weekly 8 mg/0.16 mL modified release injection, 0.16 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 8 mg/0.16 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Buvidal Weekly 24 mg/0.48 mL modified release injection, 0.48 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Buvidal Weekly 16 mg/0.32 mL modified release injection, 0.32 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 16 mg/0.32 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
exenatide 2 mg/0.85 mL modified release injection, 2 mL pen device |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
aripiprazole 400 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Abilify Maintena (aripiprazole 400 mg) modified release injection, 400 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
exenatide 2 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Sublocade 300 mg/1.5 mL modified release injection, 1.5 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 100 mg/0.5 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Sublocade 100 mg/0.5 mL modified release injection, 0.5 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 300 mg/1.5 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Lucrin Depot Paediatric (leuprorelin acetate 30 mg) modified release injection, 30 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
leuprorelin acetate 22.5 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
leuprorelin acetate 45 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Lucrin Depot 3-Month (leuprorelin acetate 22.5 mg) modified release injection, 22.5 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Lucrin Depot 6-Month (leuprorelin acetate 45 mg) modified release injection, 45 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
leuprorelin acetate 7.5 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Lucrin Depot (leuprorelin acetate 7.5 mg) modified release injection, 7.5 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
leuprorelin acetate 30 mg modified release injection, chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Lucrin Depot 4-Month (leuprorelin acetate 30 mg) modified release injection, 30 mg chamber |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
methylprednisolone acetate 40 mg/mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Depo-Medrol 40 mg/mL modified release injection, 1 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Depo-Nisolone 40 mg/mL modified release injection, 1 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Cabenuva Rilpivirine 900 mg/3 mL modified release injection, 3 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
cabotegravir 600 mg/3 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
rilpivirine 600 mg/2 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
cabotegravir 400 mg/2 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
rilpivirine 900 mg/3 mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Cabenuva Rilpivirine 600 mg/2 mL modified release injection, 2 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
buprenorphine 160 mg/0.45 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Buvidal Monthly 160 mg/0.45 mL modified release injection, 0.45 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
olanzapine (as pamoate) 300 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Zyprexa Relprevv (olanzapine (as pamoate) 300 mg) modified release injection, 300 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
olanzapine (as pamoate) 210 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
olanzapine (as pamoate) 405 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Zyprexa Relprevv (olanzapine (as pamoate) 210 mg) modified release injection, 210 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Zyprexa Relprevv (olanzapine (as pamoate) 405 mg) modified release injection, 405 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
pasireotide (as embonate) 20 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
pasireotide (as embonate) 40 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Signifor LAR (pasireotide (as embonate) 20 mg) modified release injection, 20 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Signifor LAR (pasireotide (as embonate) 40 mg) modified release injection, 40 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
pasireotide (as embonate) 60 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Signifor LAR (pasireotide (as embonate) 60 mg) modified release injection, 60 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Octreotide Depot (Teva) (octreotide 10 mg) modified release injection, 10 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Octreotide Depot (Teva) (octreotide 30 mg) modified release injection, 30 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Octreotide Depot (Teva) (octreotide 20 mg) modified release injection, 20 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Invega Hafyera 700 mg/3.5 mL modified release injection, 3.5 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
paliperidone 1 g/5 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Invega Hafyera 1 g/5 mL modified release injection, 5 mL syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
paliperidone 700 mg/3.5 mL modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Apretude 600 mg/3 mL modified release injection, 3 mL vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Invega Sustenna 150 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
paliperidone 100 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
paliperidone 25 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
paliperidone 50 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
paliperidone 75 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
paliperidone 150 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
leuprorelin acetate 7.5 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
olanzapine 405 mg modified release injection, vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
octreotide 30 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
risperidone 25 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
lanreotide 30 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
leuprorelin acetate 30 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
octreotide 20 mg modified release injection, 20 mg vial (medicinal product unit of use) |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
leuprorelin acetate 22.5 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
olanzapine 210 mg modified release injection, vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
risperidone 37.5 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
leuprorelin acetate 45 mg injection: modified release, syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
olanzapine 300 mg modified release injection, vial |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
octreotide 10 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
risperidone 50 mg modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Risperdal Consta (risperidone 25 mg) modified release injection, 25 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
morphine sulfate pentahydrate 10 mg/mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Eligard 6 Month (leuprorelin acetate 45 mg) injection: modified release, syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
Risperdal Consta (risperidone 37.5 mg) modified release injection, 37.5 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Depodur 10 mg/mL modified release injection, vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Synacthen Depot 1 mg/mL modified release injection, ampoule |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
tetracosactide 1 mg/mL modified release injection, ampoule |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Lucrin Depot 4-Month (leuprorelin acetate 30 mg) modified release injection, 30 mg syringe |
has manufactured dose form |
False |
modified release injection |
Inferred relationship |
Some |
|
Invega Sustenna 100 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Sandostatin LAR (octreotide 20 mg) modified release injection, 20 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Sandostatin LAR (octreotide 10 mg) modified release injection, 10 mg vial |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Invega Sustenna 50 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|
Invega Sustenna 25 mg modified release injection, syringe |
has manufactured dose form |
True |
modified release injection |
Inferred relationship |
Some |
|